Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis

BACKGROUND AND PURPOSE: Delayed-release dimethyl fumarate (DMF, also known as gastro-resistant DMF), demonstrated efficacy and safety in relapsing−remitting multiple sclerosis in the 2-year, randomized, placebo-controlled, phase 3 DEFINE and CONFIRM trials. A post hoc analysis of integrated data fro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Neurol
Main Authors: Kappos, L, Giovannoni, G, Gold, R, Phillips, J T, Arnold, D L, Hotermans, C, Zhang, A, Viglietta, V, Fox, R J
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2015
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674988/
https://ncbi.nlm.nih.gov/pubmed/25557371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.12624
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares